Abstract Purpose of Review Acinetobacter baumannii (AB) is an infamous nosocomial
pathogen with a seemingly limitless capacity for antimicrobial resistance, leading to few …

In total, 96 carbapenem-resistant isolates of Acinetobacter baumannii were obtained from 25
hospitals in 17 European countries. Imipenem MICs ranged from< 4 to 128 mg/L on retesting …

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-
associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is …

The global emergence of multidrug resistance (MDR) among Gram-negative bacteria has
dramatically limited the therapeutic options. During the last two decades, Acinetobacter …

Multidrug-resistant Acinetobacter baumannii has emerged as a serious nosocomial
pathogen in certain areas. In Brooklyn, New York, citywide surveillance revealed that∼ 2 of …

Over the past two decades, Acinetobacter baumannii has emerged as a leading cause of
nosocomial infections worldwide. Of particular concern are panresistant strains, leading the …

Objectives To investigate the presence of resistance genes in nosocomial multidrug-
resistant (MDR) Acinetobacter baumannii isolated from outbreak and sporadic settings …

To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and
define individual risk factors for MDR, we used epidemiologic methods, performed organism …

To give an update on the molecular epidemiology and global distribution of carbapenemase
encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated …

ABSTRACT A total of 49 unique clinical isolates of multidrug-resistant (MDR) Acinetobacter
baumannii identified at a tertiary medical center in Pittsburgh, Pennsylvania, between …